Technical Analysis for AVTX - Avalo Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 13.54 | 10.85% | 1.33 |
AVTX closed up 4.99 percent on Monday, April 22, 2024, on 10 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 10.85% | |
| Wide Bands | Range Expansion | 10.85% | |
| Oversold Stochastic | Weakness | 10.85% | |
| Doji - Bullish? | Reversal | 16.38% | |
| Wide Bands | Range Expansion | 16.38% | |
| Down 3 Days in a Row | Weakness | 16.38% | |
| Oversold Stochastic | Weakness | 16.38% | |
| Fell Below 20 DMA | Bearish | 12.70% | |
| Stochastic Reached Oversold | Weakness | 12.70% | |
| Wide Bands | Range Expansion | 12.70% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 26 minutes ago |
| Up 10% | 26 minutes ago |
| Up 5% | 32 minutes ago |
| Up 3% | 37 minutes ago |
| Up 2% | 37 minutes ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company has built a diverse portfolio of innovative therapies to deliver meaningful medical impact for patients in urgent need. The company’s clinical candidates commonly have a proven mechanistic rationale, biomarkers and/or an established proof-of-concept to expedite and increase the probability of success.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1130.4 |
| 52 Week Low | 3.9501 |
| Average Volume | 828,004 |
| 200-Day Moving Average | 22.72 |
| 50-Day Moving Average | 8.30 |
| 20-Day Moving Average | 13.65 |
| 10-Day Moving Average | 14.08 |
| Average True Range | 2.53 |
| RSI (14) | 51.22 |
| ADX | 43.3 |
| +DI | 40.40 |
| -DI | 21.21 |
| Chandelier Exit (Long, 3 ATRs) | 26.87 |
| Chandelier Exit (Short, 3 ATRs) | 12.02 |
| Upper Bollinger Bands | 22.27 |
| Lower Bollinger Band | 5.03 |
| Percent B (%b) | 0.42 |
| BandWidth | 126.26 |
| MACD Line | 1.41 |
| MACD Signal Line | 2.07 |
| MACD Histogram | -0.6613 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.08 | ||||
| Resistance 3 (R3) | 15.14 | 14.26 | 14.60 | ||
| Resistance 2 (R2) | 14.26 | 13.53 | 14.22 | 14.44 | |
| Resistance 1 (R1) | 13.23 | 13.08 | 13.75 | 13.17 | 14.28 |
| Pivot Point | 12.35 | 12.35 | 12.60 | 12.31 | 12.35 |
| Support 1 (S1) | 11.32 | 11.62 | 11.84 | 11.26 | 10.14 |
| Support 2 (S2) | 10.44 | 11.17 | 10.40 | 9.98 | |
| Support 3 (S3) | 9.41 | 10.44 | 9.82 | ||
| Support 4 (S4) | 9.35 |
